DANAZOL Safety Questions, DANAZOL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DANAZOL. Our extensive database of DANAZOL adverse events and DANAZOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DANAZOL
DANAZOL Safety Reports
Total DANAZOL reports: 4.DANAZOL FDA safety alerts: No.
Reported hospitalizations: 3.
Take DANAZOL Side Effects Survey or Share Your DANAZOL Story. DANAZOL Usage.
Pharmacist from UNITED STATES reported DANAZOL problem on Jan 02, 2007. Female patient, 86 years of age, weighting 150.0 lb, was diagnosed with anaemia haemolytic autoimmune and was treated with DANAZOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, hyponatraemia. DANAZOL dosage: 200 MG BID PO. During the same period patient was treated with SULFASALAZINE, ATENOLOL, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, DORZOLAMIDE, LATANOPROST OPTH, LEVOTHYROXINE, RAMIPRIL. Patient recovered.
DANAZOL problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2007. Female patient, 81 years of age, weighting 154.3 lb, was diagnosed with idiopathic thrombocytopenic purpura, hyperlipidaemia and was treated with DANAZOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, chromaturia, dyspnoea exertional, exercise lack of, gait disturbance, liver function test abnormal, muscle tightness, muscular weakness, musculoskeletal discomfort. DANAZOL dosage: 200MG BID PO. During the same period patient was treated with SIMVASTATIN, OMEPRAZOLE, METOPROLOL SUCCINATE, LISINOPRIL, TRAMADOL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported DANAZOL problem on Dec 05, 2006. Female patient, 41 years of age, was diagnosed with menorrhagia, pain and was treated with DANAZOL. After drug was administered, patient experienced the following problems/side effects: carotid artery dissection, hemiparesis. DANAZOL dosage: unknown. During the same period patient was treated with DIHYDROCODEINE BITARTRATE, TRAMADOL. Patient was hospitalized and became disabled. Patient recovered.
DANAZOL problem was reported by a Pharmacist from UNITED STATES on Dec 11, 2006. Female patient, 86 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with DANAZOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, crohn's disease, hepatic enzyme increased, hyponatraemia, weight increased. DANAZOL dosage: 200 MG, BID, ORAL. During the same period patient was treated with PREDNISONE, ATENOLOL, NEXIUM, FOLIC ACID, SYNTHROID, BACTRIM, SULFASALAZINE, FLAGYL. Patient was hospitalized. Patient recovered.